Literature DB >> 4539416

Virus-associated immunopathology: animal models and implications for human disease. 2. Cell-mediated immunity, autoimmune diseases, genetics, and implications for clinical research.

A C Allison, W I Beveridge, W C Cockburn, J East, H C Goodman, H Koprowksi, P H Lambert, J J van Lochem, P A Miescher, C A Mimms, A L Notkins, G Torrigiani.   

Abstract

Part 2 of this memorandum describes further mechanisms whereby the interaction of a virus with the host's immune system may lead to tissue damage. Cell-mediated immunity plays a vital role in promoting recovery from virus infections, but under some circumstances tissue damage may be caused by the reaction of immune cells with viral antigens. When mice are infected with lymphocytic choriomeningitis virus neonatally or as adults while receiving immunosuppressive drugs, widespread invasion of cells is seen but there is little overt disease. If, however, normal adults are infected or if immune cells are transfused into tolerant mice, cell injury and death follow. Viruses have long been suspected of contributing to the pathogenesis of autoimmune diseases. Antibodies directed against normal cell constituents have been reported in several virus infections. Viruses may conceivably unmask or release host antigens, alter host antigens and act as "helper determinants", or perhaps in other ways provoke immune responses against normal body constituents. The immunopathological manifestations caused by viruses may also be influenced by the host's genetic makeup. Certain observations indicate that, in addition to controlling susceptibility to virus infection, genetic factors partly determine the effectiveness of the immune response. The memorandum calls attention to the possible implications of these concepts and findings for clinical research. Some of the diseases of animals and man that serve as models for studies of virus-associated immunopathology are briefly described.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4539416      PMCID: PMC2480896     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  21 in total

1.  Studies on the innate resistance of mice to infection with mousepox. I. Resistance and antibody production.

Authors:  K SCHELL
Journal:  Aust J Exp Biol Med Sci       Date:  1960-08

2.  Pathogenesis of lesions in lymphoid tissue of mice infected with lymphocytic choriomeningitis (LCM) virus.

Authors:  C A Mims; F A Tosolini
Journal:  Br J Exp Pathol       Date:  1969-12

3.  Naturally occurring immune-complex glomerulonephritis in the cat.

Authors:  D O Slauson; S W Russell; R D Schechter
Journal:  J Pathol       Date:  1971-02       Impact factor: 7.996

4.  An in vitro measure of cellular immunity to fibroma virus.

Authors:  W A Tompkins; C Adams; W E Rawls
Journal:  J Immunol       Date:  1970-02       Impact factor: 5.422

5.  Immunologic abnormalities in subacute sclerosing panencephalitis.

Authors: 
Journal:  N Engl J Med       Date:  1972-04-06       Impact factor: 91.245

6.  Equine infectious anemia: a model of immunoproliferative disease.

Authors:  R A Squire
Journal:  Blood       Date:  1968-07       Impact factor: 22.113

7.  Effect of murine strain and viral strain on the pathogenesis of lymphocytic choriomeningitis infection and a study of footpad responses.

Authors:  F A Tosolini; C A Mims
Journal:  J Infect Dis       Date:  1971-02       Impact factor: 5.226

8.  Systemic lupus erythematosus and myxovirus.

Authors:  F Györkey; K W Min; J G Sincovics; P Györkey
Journal:  N Engl J Med       Date:  1969-02-06       Impact factor: 91.245

9.  Hepatitis and Australia antigen: autosomal recessive inheritance of susceptibility to infection in humans.

Authors:  B S Blumberg; J S Friedlaender; A Woodside; A I Sutnick; W T London
Journal:  Proc Natl Acad Sci U S A       Date:  1969-04       Impact factor: 11.205

10.  Canine systemic lupus erythematosus. Genetic analysis of an established breeding colony.

Authors:  R M Lewis; R S Schwartz
Journal:  J Exp Med       Date:  1971-08-01       Impact factor: 14.307

View more
  2 in total

1.  Demonstration of a blocking factor in the plasma and spinal fluid of patients with subacute sclerosing panencephalitis. I. Partial characterization.

Authors:  A Ahmed; D M Strong; K W Sell; G B Thurman; R C Knudsen; R Wistar; W R Grace
Journal:  J Exp Med       Date:  1974-04-01       Impact factor: 14.307

2.  Persistent viral infections as models for research in virus chemotherapy.

Authors:  G Streissle
Journal:  Adv Virus Res       Date:  1981       Impact factor: 9.937

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.